Shoshana Segal
- Molecular Biology top 5%
- Oncology top 5%
- Genetics top 10%
- Hepatology top 5%
- Cancer Research top 10%
- Co-authors
- Marion M. NauJohn D. MinnaJ FedorkoJ D MinnaJean VialletJ. SchütteMiriam R. AnverJames H. Resau
- Topics
- Ubiquitin and proteasome pathways (8 papers)Cancer-related Molecular Pathways (8 papers)Virus-based gene therapy research (7 papers)
- Cited by
- OncologyHepatologyMolecular Biology
- Partner nations
- United StatesIsraelUkraine
In The Last Decade
Shoshana Segal
39 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 1.5k
- Oncology 794
- Genetics 330
- Hepatology 227
- Cancer Research 216
Countries citing papers authored by Shoshana Segal
This map shows the geographic impact of Shoshana Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoshana Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoshana Segal more than expected).
Fields of papers citing papers by Shoshana Segal
This network shows the impact of papers produced by Shoshana Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoshana Segal. The network helps show where Shoshana Segal may publish in the future.
Co-authorship network of co-authors of Shoshana Segal
This figure shows the co-authorship network connecting the top 25 collaborators of Shoshana Segal. A scholar is included among the top collaborators of Shoshana Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoshana Segal. Shoshana Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 7 | |
| 3 | 21 | |
| 4 | 61 | |
| 5 | 18 | |
| 6 | 6 | |
| 7 | 7 | |
| 8 | 64 | |
| 9 | 18 | |
| 10 | 313 | |
| 11 | 1 | |
| 12 | Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. | 16 |
| 13 | 17 | |
| 14 | 429 | |
| 15 | 3 | |
| 16 | 3 | |
| 17 | 10 | |
| 18 | 2 | |
| 19 | 60 | |
| 20 | 84 |
About Shoshana Segal
Shoshana Segal is a scholar working on Oncology, Molecular Biology and Genetics, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Cancer-related Molecular Pathways (8 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Oncology (794 citations), Hepatology (227 citations) and Molecular Biology (1.5k citations). Shoshana Segal has collaborated with scholars based in United States, Israel and Ukraine. Frequent co-authors include Marion M. Nau, John D. Minna, J Fedorko, J D Minna, Jean Viallet, J. Schütte, Miriam R. Anver, James H. Resau, George F. Vande Woude and Sing Rong. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.